BioNTech SE (BNTX)
88.23
-1.97
(-2.18%)
USD |
NASDAQ |
Oct 16, 12:46
BioNTech SG&A Expense (TTM) : 833.57M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 833.57M |
| March 31, 2026 | 759.44M |
| December 31, 2025 | 709.95M |
| September 30, 2025 | 597.23M |
| June 30, 2025 | 589.02M |
| March 31, 2025 | 631.04M |
| December 31, 2024 | 648.03M |
| September 30, 2024 | 643.05M |
| June 30, 2024 | 650.58M |
| March 31, 2024 | 605.95M |
| December 31, 2023 | 603.23M |
| September 30, 2023 | 607.55M |
| June 30, 2023 | 589.53M |
| Date | Value |
|---|---|
| March 31, 2023 | 593.59M |
| December 31, 2022 | 570.29M |
| September 30, 2022 | 600.12M |
| June 30, 2022 | 538.05M |
| March 31, 2022 | 454.41M |
| December 31, 2021 | 393.84M |
| September 30, 2021 | 274.79M |
| June 30, 2021 | 214.27M |
| March 31, 2021 | 164.69M |
| December 31, 2020 | 125.32M |
| September 30, 2020 | 74.29M |
| June 30, 2020 | 42.04M |
| March 31, 2020 | 17.96M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.629M |
| Moderna, Inc. | 965.00M |
| Mereo BioPharma Group Plc | 19.44M |
| NuCana Plc | 7.064M |
| Immatics NV | 63.90M |